MEEI has new laser to treat diabetic retinopathy

The Massachusetts Eye and Ear Infirmary (MEEI) acquired the newest laser for treating diabetic retinopathy.

Boston-The Massachusetts Eye and Ear Infirmary (MEEI) acquired the newest laser for treating diabetic retinopathy. The pattern scan laser photocoagulator (Pascal, OptiMedica) places an array of lower energy pulses across the retina, allowing patients to receive treatment in a single session as opposed to multiple sessions.

Also, the treatment results in less inflammation and blurring of vision after treatment.

"{MEEI's] acquisition of the laser, in combination with current technologies available at the hospital, including the retinal angiograph [Spectralis, Heidelberg] and optical coherence tomography (OCT), and spectral domain OCT [Carl Zeiss Meditec], make MEEI state of the art for retina diagnosis and treatment," said Joan W. Miller, MD, MEEI chief of ophthalmology and chairwoman of ophthalmology at Harvard Medical School. "Having the best tools helps our doctors give the very best care for patients."